Shares of Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) traded up 10.7% during mid-day trading on Monday . The stock traded as high as $451.07 and last traded at $449.8450. 844,785 shares changed hands during trading, a decline of 85% from the average daily volume of 5,677,063 shares. The stock had previously closed at $406.42.
Analyst Ratings Changes
A number of equities analysts have commented on ALAB shares. Susquehanna lifted their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Evercore reiterated an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research note on Tuesday, May 19th. Bank of America increased their target price on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. JPMorgan Chase & Co. raised their price target on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Finally, Roth Mkm reaffirmed a “buy” rating and issued a $275.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus target price of $265.75.
Read Our Latest Stock Analysis on ALAB
Astera Labs Stock Performance
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue was up 93.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.
Insiders Place Their Bets
In related news, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the completion of the transaction, the director owned 57,466 shares of the company’s stock, valued at $25,859,700. This trade represents a 5.75% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 1,981,441 shares of company stock valued at $444,969,514. Corporate insiders own 10.40% of the company’s stock.
Hedge Funds Weigh In On Astera Labs
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ALAB. Eurizon Capital SGR S.p.A. acquired a new stake in shares of Astera Labs during the 4th quarter valued at $18,708,000. Nordea Investment Management AB purchased a new position in shares of Astera Labs during the 4th quarter valued at $2,028,000. Swedbank AB increased its stake in shares of Astera Labs by 76.8% in the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after acquiring an additional 33,940 shares during the last quarter. Numerai GP LLC raised its stake in shares of Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after purchasing an additional 7,992 shares in the last quarter. Finally, Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new stake in shares of Astera Labs during the 4th quarter worth about $499,000. Institutional investors and hedge funds own 60.47% of the company’s stock.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- This Edge AI Stock Just Got a Huge Vote of Confidence From Wall Street
- AI Is Selling Off, But These 5 Stocks Could Benefit Next
- These 3 Stocks Offer Investors Exposure to the Functional Beverage Boom
- Alcoa’s $4.1 Billion South32 Deal: Opportunity Behind the 9% Drop
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
